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Abstract
Purpose The purpose of this study was to assess the psychometric properties of the Satisfaction with Life Scale (SWLS), 
evaluate the measurement invariance with respect to sex, age, and tumor location, as well as analyze associations between 
life satisfaction and socio-demographic and clinical variables among individuals with resected, non-advanced cancer.
Methods A confirmatory factor analysis was conducted to explore the dimensionality of the scale and test invariance across 
gender, age, and tumor localization in a prospective, multicenter cohort of 713 patients who completed the following scales: 
SWLS, Health-related Quality of Life Questionnaire (EORTC QLQ-C30), Brief Symptom Inventory (BSI-18).
Results Confirmatory factor analysis results indicated that the SWLS is an essentially unidimensional instrument, provid-
ing accurate scores: both McDonald’s omega and Cronbach’s alpha estimates were 0.91. Strong measurement invariance 
was found to hold across gender, age, and tumor localization. Low satisfaction with life was associated with psychological 
symptoms (anxiety, depression, and somatization), and decreased quality of life (malfunction, symptoms, poor global QoL).
Conclusion The SWLS is a reliable, valid satisfaction with life measurement among people with cancer and should be rec-
ommended as an indicator of psychological adjustment in oncological patients.
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Introduction
Cancer is a complex, multifarious disease, the incidence of 
which continues to grow in developed countries, reaching 
1.3 million new cases each year in Europe [1]. Treatments 
have improved over the last decade, leading to a notice-
able increase in cancer survivors [2]. Intensive therapies 
are responsible for these advances, albeit at the expense 
of formidable side effects (e.g., infertility, heart problems, 
endocrine dysfunction, post-traumatic stress, or neuropsy-
chological deficits) [3, 4]. Physical and psychological 
changes, and the decline observed in patients owing to the 
direct effects of the cancer itself, comorbidities, and treat-
ments result in the need to understand the biopsychosocial 
impact of the disease and its long-term treatment [2].
The Satisfaction with Life Scale (SWLS) is extensively 
used to quantify the cognitive component of subjective 
well-being [5], examining a person’s expectations against 
their achievements [6]. A recent conceptual paper con-
sidered that satisfaction with life is a type of evaluative 
well-being that, together with hedonic well-being and 
eudemonic well-being, constitutes a measure of subjec-
tive well-being [7].
In studies conducted in the general population, satisfac-
tion with life has been found to be independent of gender 
[8, 9], level of education, employment status, and social 
support [10]. Low satisfaction with life has been correlated 
with having physical (fatigue, physical complaints, insom-
nia, and low quality of life) and psychological (anxiety and 
pessimism) problems in the general population [8] and in 
patients with colorectal cancer [11]. Likewise, it has been 
linked to socio-demographic factors (not having a part-
ner, low income, and unemployment) both in the general 
population [8] and in individuals with prostate cancer [12]. 
Among breast cancer patients, satisfaction with life has 
been related to having children, being employed, having 
social and emotional support, and being in good physi-
cal and psychological condition [13], as well as actively 
engaged in shared decision-making [14].
Thus, life satisfaction in individuals with cancer is a 
relevant quality-of-life indicator [15] and has been used 
both as an outcome measure, as it relates to recovery 
from disease, and as an indicator of adaptation to new life 
conditions [13]. Furthermore, people with cancer display 
lower levels of satisfaction with life versus those suffering 
from chronic illness (diabetes, osteoporosis, respiratory 
failure) [15]. Dissatisfaction with life is related to psycho-
logical distress in oncology patients [16] and lower qual-
ity of life [17]. Women who had undergone mastectomy 
and/or breast reconstructive surgery had lower levels of 
satisfaction and lower quality of life, compared to those 
who had undergone breast-conserving surgery [17, 18]. 
A longitudinal study with nearly 2000 colorectal cancer 
survivors found that less optimism and a higher use of 
threat appraisals were associated with poorer life satisfac-
tion [11].
We must analyze patients’ satisfaction with life if we are 
to understand the domains in which they feel a discrepancy 
between their expectations and achievements and their cur-
rent health status, as well as the areas in which they may 
need support. The SWLS, a multi-item questionnaire devel-
oped in the United States in 1985, widely used and validated 
in numerous countries [9, 19–21] enables us to do just that. 
Internal consistency reliability coefficients range from 0.79 
to 0.91 [6, 21]. The SWLS has good divergent validity for 
constructs such as depression, anxiety, and psychological 
distress [6], and convergent validity with other measures 
of subjective well-being [22]. The scale’s factorial invari-
ance has aroused interest in recent studies and it is important 
to be able to compare results across different genders and 
age groups, amongst others [19, 23–25]. Nevertheless, so 
far as we know, the scale’s psychometric properties and its 
invariance across oncological patients’ gender, age, tumor 
type, socio-demographic, and clinical factors have yet to be 
evaluated.
The aim of this study is to examine the SWLS’s psy-
chometric properties and assess the effect of gender, age, 
and tumor type, as well as the relation between satisfac-
tion with life and variables of clinical relevance and socio-
demographic factors in a sample of individuals with cancer 
initiating adjuvant chemotherapy. A high or moderate cor-
relation between the SWLS and Europe QoL, and psycho-
logical scales of BSI is expected for the convergent validity.
Methods
Study populations
The Neocoping project is a national, multicenter (15 cent-
ers), cross-sectional, prospective study of the Continuous 
Care Group of the Spanish Society of Medical Oncology 
(SEOM). The protocol was approved by the Ethics commit-
tee of each hospital, and by the Spanish Agency for Medi-
cines and Medical Devices (AEMPS); all participants signed 
informed consent forms prior to inclusion. The population 
consisted of patients with histologically confirmed, non-
advanced cancer treated with surgery for which international 
clinical guidelines considered that adjuvant treatment could 
be an option. Subjects were excluded if they were under 
18 years of age, had been treated with preoperative radio- or 
chemotherapy, only hormonal therapy, or adjuvant radiother-
apy without chemotherapy, and if they had any serious men-
tal illness that prevented them from understanding the study. 
Self-report scales were completed by the participants at the 
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beginning of adjuvant treatment. Each questionnaire con-
tained written instructions and specified that participation 
was voluntary and anonymous. Of the 803 patients screened, 
90 were not eligible (17 did not meet inclusion criteria, 33 
met exclusion criteria, and 40 had incomplete data).
Instruments
The Satisfaction with Life Scale (SWLS) is a 5-item scale 
that assesses an individual’s global judgment regarding their 
life satisfaction [5]. Individuals were asked to indicate their 
level of agreement with the statements on a seven-point 
Likert-type scale. Raw scores ranged from 5 to 35, with 
higher scores indicating greater life satisfaction. We used 
the Spanish version of the SWLS [19]. The unidimensional 
structure of the scale has been confirmed in different studies 
conducted in Spanish populations [9, 10].
The Brief Symptom Inventory (BSI-18) includes 18 symp-
toms to appraise distress on a five-point scale ranging from 
‘not at all’ (0) to ‘extremely (4)’ [26]. The scale provides 
three groups of symptoms (somatization, depression, and 
anxiety) and a total score, known as the Global Severity 
Index (GSI), which compiles the interviewee’s psychologi-
cal distress. Cronbach’s alpha ranged from 0.81 to 0.90 [26].
The European Organization for Research, and Treatment 
of Cancer Quality of Life Questionnaire (EORTC QLQ-
C30) is widely used in Europe to assess quality of life, and 
its validity has been well established [27]. Response choices 
range from 1 (not at all) to 4 (very much), with the excep-
tion of the global QoL scale, where responses range from 
1 (very poor) to 7 (excellent). All scale scores are linearly 
transformed to a 0–100 scale. Higher scores on the function-
ing scales and global QoL scale represent a higher level of 
functioning or QoL. For the symptom scales, the higher the 
score, the greater the symptom burden.
Demographic and clinical variables consisted of age, 
gender, marital status (married/partnered, not partnered), 
five age groups (≤ 49, 50–59, 60–69, ≥ 70 years), employ-
ment status (inactive, active), tumor (colon, breast, others), 
cancer treatment (chemotherapy, chemotherapy, and radio-
therapy), and tumor stage (I–II, III).
Data analysis
Data analysis was performed using a 3-stage approach. First, 
basic sample and item descriptive statistics were obtained by 
using SPSS v23, then, confirmatory factor analyses (CFA’s) 
were performed in two steps. In the preliminary step, the 
unidimensional FA model assumed for the SWLS items was 
fitted to the entire patient sample. The second step consisted 
of evaluating measurement invariance in groups defined by 
gender, age, and tumor localization. All FA models were 
fitted using robust maximum likelihood (RML) estimation 
with second-order (mean and variance) corrections as imple-
mented in Mplus (see [28], Appendix 4). Model fit and 
appropriateness were assessed with three groups of meas-
ures. First, model residuals and relative fit were appraised 
with the SRMR and RMSEA statistics. Second, relative 
comparative fit was evaluated with the CFI index (as a rela-
tive measure of fit with respect to the null independence 
model). Finally, in the overall analysis, additional indices of 
appropriateness to examine the strength and replicability of 
the solution (H index), as well as closeness to unidimension-
ality (ECV index), were also obtained by using the FACTOR 
program [29, 30]. As for reference values, CFI values ≥ 0.95 
are indicative of good model fit [31], whereas SRMR val-
ues ≤ 0.08 and RMSEA values ≤ 0.06 indicate satisfactory 
fit [32, 33].
In the factor-analytic framework, the property of meas-
urement invariance (MI) means that, in all the groups to 
be compared, the instrument which is assessed measures 
the same dimensions with the same factorial structure (see 
[34]). In our case, MI would imply that the SWL items (a) 
conform to the unidimensional model in all the groups to be 
compared and (b) have the same quality and measurement 
properties across the groups. Within this general framework, 
and, as discussed below, there are different levels of MI that 
can be considered or attained.
As in most clinical studies, the main relevance of MI is 
that it is a prerequisite for validly interpreting and comparing 
scores obtained from the instrument under study. Thus, if MI 
holds, this means that the scores of two individuals belong-
ing to different groups can be validly compared, because 
eventual differences in these scores univocally reflect ‘true’ 
differences on the trait that is measured. And the same 
occurs when mean differences are observed among groups. 
On the contrary, when MI cannot be demonstrated, valid 
interpretation of score differences is not warranted. In this 
case, the observed differences might reflect that the indi-
viduals of the different groups interpret the item questions 
differentially (see [34]) or, even worse, that the instrument 
measures different dimensions in the different groups.
There is considerable debate surrounding the appro-
priate level of MI to be recommended for a measurement 
instrument. The most complete form implies invariance in 
the item thresholds, loadings, and error variances, and is 
known in the literature as strict factorial invariance [35]. 
Strict invariance, however, represents an often unattainable 
ideal in applied research and is not strictly necessary for the 
present purposes; moreover, when forced in a solution, it can 
lead to biased parameter estimates (e.g., [36]). We therefore 
considered strong or scalar invariance [35] to be a reason-
able aim for the SWLS items. Strong invariance implies 
that both item intercepts and loadings are invariant, and if 
attained, that any systematic group differences in means and 
covariances are due to common factors. Furthermore, when 
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measuring individuals from different groups, the measure-
ment scale can be considered to be the same and trait esti-
mates comparable (see [37]). Figure 1 depicts the measure-
ment invariance diagram for the SWL items in the two-group 
case. Note that in both groups, the same factor (i.e., satisfac-
tion with life) is measured with the same regression param-
eters (note that the intercepts µ and loadings λ have the same 
common subscripts in both groups) and only the residual 
terms or errors are allowed to have different magnitudes in 
each group (these terms have additional group subscripts).
Provided that strong invariance was obtained, the mean 
differences in groups defined by gender, age, and tumor site 
were assessed in this second, CFA stage. The reliabilities 
of the scores derived from the factorial solution were also 
examined at the end of this stage using Cronbach’s alpha and 
MacDonald’s Omega.
In the third stage, validity relations were assessed via 
product-moment correlations between SWLS and EORTC 




The study included 713 patients with cancer (57.8% females 
and 42.2% males), aged 18–75 years (M = 59.3, SD = 12.2), 
consecutively referred to the Department of Medical Oncol-
ogy at each hospital, predominantly married or partnered 
(75.9%), and unemployed (58.2%). The most common 
tumor site was colon (43.8%) and breast (31.6%), stage I–II 
(55.5%); all patients received adjuvant chemotherapy and 
33.2% also received radiotherapy; see Table 1.
The lowest life satisfaction scores were observed for 
patients who were unmarried, widowed, or divorced 
(M = 24.6), who presented marginally lower values than 
those who were married or partnered (M = 27.8; F = 39.458 
p < 0.001; η2 = 0.05), and for young people (F = 3.999, 
p = 0.008; η2 = 0.02). The lowest satisfaction scores were 
found for people aged < 49 years (M = 25.9) compared 
to those aged 60–69 years (I–J = − 1.70, p = 0.036), and 
≥ 70 years (I–J = − 1.92, p = 0.019); see Table 1.
Descriptive statistics for SWLS items
Descriptive statistics of the five items of the SWLS are 
presented in Table 2. The mean score obtained was 27.1 
(SD = 5.9) and all five items exhibited very similar means, 
5.10–5.78 on the 1–7 scale. SWLS item score distributions 
were unimodal and asymmetrical (negatively skewed), 
thereby indicating that most of the values were concentrated 
at the highest end of the response scale. All the corrected 
item-total correlations surpassed 0.66. Provided that the 
scale behaves unidimensionally, this last result indicates 
that the items have adequate discriminating power and are 
strongly related to the construct they measure.
Confirmatory factor analysis and measurement 
invariance
Because (a) response variables are ordered-categorical, 
(b) item distributions are negatively skewed, and (c) item 
discriminating power is relatively high, the most ‘a priori’ 
appropriate factor analysis procedure for the SWLS items 
is the underlying-variables approach (UVA), fitting the FA 
model to the inter-item polychoric correlation matrix (more 
details in [38]). However, the number of scale response 
points is relatively high and we found that the results of fit-
ting the UVA-based model and the standard linear FA model 
were virtually the same. Given this result, plus the fact that 
applying the linear model considerably simplifies assess-
ment of the measurement invariance, we opted to use the 
linear approach in all the FA analyses that follow.
As described above, the unidimensional FA model was 
first fitted in the entire sample of 713 respondents. As 
expected from previous studies, the fit of the unidimensional 
model was quite acceptable (χ2 = 15.79, df = 5; CFI = 0.99, 
RMSEA = 0.056, and SRMR = 0.02). The ECV estimate was 
0.947, meaning that 94.7% of the common variance of the 
item scores can be accounted for by the single factor. Finally, 
the replicability H index was 0.953, indicating not only that 
the solution is essentially unidimensional, but also that the 
single factor is strong and replicable [29]. The estimated 
intercepts obtained by fitting the FA model were essentially 
the same as the item means given in Table 2. Standardized 
























Fig. 1  Satisfaction with Life Scale (SWLS) mean score by marital 
status and age group
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As for invariance, similar to previous studies [9, 19, 
21, 23, 24], strong measurement invariance was attained 
for both gender and age. Table 3 presents the results of 
the strong invariance model for gender and age, as well as 
mean group estimates. As discussed above, the attainment 
of this MI level allows us to assume that the same con-
struct is measured in the different gender and age groups 
and that the regression parameters of the SWL items 
are the same (i.e., invariant) in these groups. Therefore, 
group mean score differences can be validly interpreted 
as reflecting ‘true’ group differences in the construct that 
is measured. With regards to this interpretation, note that 
the mean satisfaction estimate is lower in Women with a 
statistically significant difference, given that the fixed 0 
estimate in Men falls outside the 95% confidence inter-
val around the Women mean. However, the upper limit of 
the confidence interval is almost zero and the effect size 
for mean differences (Cohen’s d) is a mere 0.17. In short, 
these results suggest that there is a significant difference 
in satisfaction with life in the direction that said scores 
are lower in the Women. However, statistical significance 
is probably due to the power of the test with the large 
Table 1  Association between 
SWLS and socio-demographic 
and clinical characteristics of 
the sample
Bold values indicate the significant at 5% level
Characteristics n % M SD F p
Gender
 Male 301 42.2 27.5 6.0 3.514 0.061
 Female 412 57.8 26.7 5.9
Marital status 39.458 < 0.001
 Married or partnered 541 75.9 27.8 5.5
 Single/widow, divorced 172 24.1 24.6 6.5
Age group (years) 3.999 0.008
 ≤ 49 168 23.6 25.9 6.7
 50–59 168 23.6 26.6 5.4
 60–69 207 29.0 27.6 5.6
 ≥ 70 167 23.4 27.8 5.9
Employment status 0.661 0.416
 Inactive 415 58.2 27.2 6.0
 Active 298 41.8 26.8 5.7
Tumor localization 1.563 0.210
 Colon 312 43.8 27.5 5.8
 Breast 225 31.6 26.8 5.8
 Others 176 24.7 26.5 6.3
Tumor stage 0.167 0.683
 I–II 380 55.5 26.9 5.7
 III 305 44.5 27.1 6.2
Tumor treatment 0.323 0.570
 Chemotherapy 476 66.8 26.9 6.1
 Chemo- and radiotherapy 237 33.2 27.2 5.7
Time to diagnosis (days)
 0–6 355 55.6 26.9 6.1 0.026 0.871
 > 61 283 44.4 26.8 6.2
Table 2  Characteristics on the 
SWLS items
Items M SD Skews rit α if item deleted
1. In most ways, my life is close to my ideal 5.10 1.3 − 0.88 0.70 0.86
2. The conditions of my life are excellent 5.26 1.4 − 0.90 0.75 0.85
3. I am satisfied with my life 5.70 1.3 − 1.33 0.72 0.84
4. So far I have gotten the important things I want in my life 5.77 1.3 − 1.47 0.70 0.86
5. If I could live my life over, I would change almost nothing 5.19 1.7 − 0.95 0.66 0.88
SWLS total 27.1 5.9
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samples employed and the practical significance is likely 
negligible. This result is consistent with the less powerful 
raw score-based mean comparisons shown in Table 1, in 
which statistical significance was still not attained.
As regards age comparisons, the results shown in 
Table 3 reveal that group 1 (< 49) has significantly lower 
satisfaction-with-life levels than the remaining groups; 
again, in line with the raw score-based results shown in 
Table 1.
The results for groups defined by tumor location are 
new; consequently, they will be discussed in greater detail. 
Table 4 provides the sequential assessment results for the 
nested sub-models going from configural invariance to 
strong invariance. Given that a second-order correction was 
used in the robust ML estimation, difference testing was con-
ducted using DIFFTEST [39]. Mean group estimates are 
provided at the bottom of the table.
Results shown in Table 4 can be summarized as follows. 
First, the strong invariance submodel has quite an accept-
able fit, and, in relative terms (i.e., RMSEA), the fit is better 
than that of the less restricted configural model. Second, 
goodness-of-fit does not appear to worsen substantially 
when going from the configural to the strong model. Strictly 
speaking, the Chi-square difference test when passing from 
the weak to the strong model is statistically significant. How-
ever, the difference in CFI terms is < 0.01 and < 0.015 in 
RMSEA terms. Overall, the hypothesis that strong measure-
ment invariance is achieved when grouping by tumor site is 
quite tenable, which implies that the same valid comparisons 
that were made for gender and age can be also made here.
Group differences are quite clear: the 0 fixed mean is 
contained in both confidence intervals and these intervals, 
Fig. 2  Standardized estimates of confirmatory factor analysis of the 
five SWLS items in the entire sample
Table 3  Results of the strong 
invariance model for gender 
and age
SD Standard deviation, CFI Comparative Fit Index, SRMR standardized root mean square residual, RMSEA 
root mean square error of approximation
Groups Mean SD (95% CI) χ2 (df) CFI SRMR RMSEA (90% CI)
Gender
 Men (fixed) 0.00 37.07 (18) 0.98 0.03 0.05 (0.02; 0.07)
 Women − 0.18 0.08 (0.34; − 0.02)
Age group (years) 60.96 (44) 0.98 0.03 0.04 (0.00; 0.07)
 Group 1 (≤ 49) (fixed) 0.00
 Group 2 (50–59) 0.14 0.12 (− 0.10; 0.37)
 Group 3 (60–69) 0.32 0.12 (0.08; 0.55)
 Group 4 (≥ 70) 0.35 0.12 (0.10; 0.60)
Table 4  Assessment of SWLS invariance by tumor location: fit results and mean group estimates
df degree of freedom, CFI Comparative Fit Index, SRMR standardized root mean square residual, RMSEA root mean square error of approxima-
tion, SD standard deviation, CI confidence interval
Invariance condition χ2 df ∆χ2 Δdf CFI SRMR RMSEA
Configural 26.86 15 – – 0.99 0.03 0.058
Weak (metric) 32.79 23 7.12 8 0.99 0.05 0.042
Strong (scalar) 47.94 31 18.10 8 0.98 0.05 0.048
Tumor site Mean SD (95% CI)
Colon (fixed) 0.00
Breast − 0.16 0.09 (− 0.33, 0.02)
Others − 0.016 0.10 (− 0.36, 0.05)
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in turn, widely overlap. Thus, no significant group mean 
differences in satisfaction with life emerge.
At the end of this second step, and because the unidimen-
sional structure for the SWLS items was found to be reason-
able, the reliability of the scores derived from this structure 
was assessed. Both reliability estimates (McDonald’s omega 
and Standardized Cronbach’s alpha) were 0.91.
Convergent validity of the SWLS scores
Low satisfaction with life was associated with anxi-
ety (r = − 0.33), depression (r = − 0.42), somatization 
(r = − 0.26), functional scale (r = − 0.29), symptom scale 
(r = 0.25), and decreased global quality of life (r = − 0.32); 
see Table 5.
Discussion
This is the first study with a large sample of adults with 
non-metastatic, resected cancer with curative intent to ana-
lyze the psychometric properties of the SWLS. In line with 
other published studies, the scale exhibits high internal 
consistency, a well-defined, strong unifactorial structure, 
and achieves strong invariance in terms of gender, age, and 
tumor location.
The mean SWLS score was 27.1 in this study, slightly 
above the means obtained in studies in our setting with rep-
resentative samples of German M = 26.4 [8], Norwegian 
M = 26.2 2 [21], and Spanish M = 24.1 adult populations [10, 
15]. In this last study, half of the participants presented phys-
ical and psychological problems, which might account for 
the lower scores on the scale in comparison with the other 
studies. Insofar as patients with cancer are concerned, satis-
faction with life was also slightly higher in our sample than 
in people with colorectal cancer who had recently undergone 
surgery, many of whom received adjuvant therapy, M = 26.4 
[40], and well above that of women of child-bearing age with 
cancer (leukemia, Hodgkin and non-Hodgkin lymphoma, 
breast cancer, and gastrointestinal cancer), M = 20.0 [41], 
and women with breast cancer receiving treatment adjuvant, 
M = 18.4 [42]. We believe that our sample’s age and charac-
teristics might explain these differences. In the last two stud-
ies, the mean age was between 40 and 49 years, which coin-
cides with the age range in which our patients also exhibited 
lower satisfaction with life scores. Our series had a higher 
mean age, which could be associated with greater satisfac-
tion. As for our group’s clinical status, they had undergone 
surgery with curative intent for an early-stage cancer. This, 
despite the fear surrounding the potential risk of recurrence, 
may have influenced the high score on the Satisfaction with 
Life Scale. The participants may feel that life has given them 
a “second chance.”
The reliability (internal consistency) estimates (McDon-
ald ω and Cronbach α = 0.91) were similar to those of other 
studies: 0.89 [8], 0.91 [21], and 0.88 [10], and there is no 
item that when eliminated increases the scale’s consistency. 
Nevertheless, item no. 5 presents less saturation and the 
item-total correlation is the lowest, similar to other inves-
tigations [10, 19]. The results of the invariance study indi-
cate that there is no differential functioning in any of SWLS 
items and, therefore, that the test’s structure is equivalent 
in men and women. These results are comparable to those 
reported by several groups [9, 19, 21], although they con-
trast with those published regarding a sample of Spanish 
and Portuguese adolescents, and another sample of Serbian 
adolescents that found incomplete scaler invariance with the 
intercept for item 5 [19, 20]. Because the strong invariance 
hypothesis was found to be plausible, the mean groups could 
be meaningfully compared. Results indicated a statistically 
significant difference in the direction that satisfaction with 
life was lower in women. However, the effect size was very 
small and the practical significance was probably negligible, 
although this effect is somewhat greater than those found in 
other populational studies [8, 21].
Strong invariance was also found to be tenable in the 
age-defined groups. Our finding is compatible with previous 
reports [43, 44], although others [9, 45, 46] found that life 
satisfaction does not have the same meaning across the life 
span. Multigroup-based comparisons suggested differences 
between group 1 and the remaining groups (older people 
reporting higher levels of life satisfaction). Given that sat-
isfaction with life is a judgment between what we expect to 
obtain and what we have actually achieved [5], older indi-
viduals can be expected to score higher, since seniors have 
been able to satisfy some of their life goals, whereas younger 
people, by virtue of their age, may still be building their 
careers, families, and have greater economic responsibili-
ties and can perceive cancer as something outside the usual 
age- and health-related expectations [11].
As far as tumor site is concerned, strong invariance 
was also found to be reasonable, this being the first study 
that analyzes invariance on the basis of tumor. No sig-
nificant differences were detected between mean levels of 
Table 5  Correlations between SWLS and other scales
*p < 0.01, **p < 0.001
Scales SWLS
EORTC Functional scale − 0.29**
EORTC Symptom scale 0.25**
EORTC Global QoL − 0.32**
BSI Anxiety − 0.33**
BSI Depression − 0.42**
BSI Somatization − 0.26**
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satisfaction in the three groups: colon, breast, and others. 
Along these same lines, Dunn et al. found that half of all 
patients with cancer reported high levels of satisfaction 
with life and that the experience of having cancer did not 
bring them to judge their lives as impaired or less than 
ideal [11]. This speaks of patients’ ability to maintain a 
stable sense of satisfaction with life despite their illness 
[6, 42].
Insofar as patients’ socio-demographic and clinical vari-
ables are concerned, results based on direct test scores are as 
follows. Marital status appears to intervene in the reported 
levels of satisfaction. Married people or those living with 
a partner reported greater satisfaction with life than single, 
divorced, or widowed individuals. Furthermore, the latter 
were the group exhibiting the lowest score on the scale. 
Recent studies suggest that positive marital relationships 
contribute in the process of coping with cancer [47, 48].
As for construct validity, the closest correlations were 
observed in the negative emotional component of the BSI 
(anxiety, depression, and somatization). Associations were 
also found with quality-of-life indicators (functional status, 
symptoms, and global QoL), although slightly lower than in 
the emotional component. Many health studies have used the 
SWLS to gage quality of life in people undergoing medical 
procedures and/or rehabilitative therapies [8, 11, 13].
The findings of this study have several clinical impli-
cations. The SWLS can complement other measures that 
appraise negative states in oncological patients. As for sat-
isfaction with life, psychosocial interventions that help the 
patient maintain and enhance their sense of meaning and 
purpose in life, despite their disease, can aid in their recov-
ery and improve their quality of life, particularly in those 
who are struggling. It would be interesting in future studies 
to analyze the relationship between satisfaction and risk of 
recurrence and their ability to recover, as well as to examine 
if satisfaction with life remains stable throughout treatment.
Among the study’s limitations, we must point that since 
the study was designed to include a single satisfaction with 
life assessment, information regarding causality cannot 
be examined, nor can we offer an explanation about how 
satisfaction evolves over time. Second, though we have a 
large sample, it is possible that those who did not want to 
participate because they were tired, anguished, or in worse 
health (n = 66) might have caused the results to vary. Third, 
specific factors that might account for satisfaction with life 
such as resilience were not assessed; this is an area for future 
research. Finally, the possibility exists that the results of our 
study might not be susceptible to extrapolation to individuals 
with advanced tumors, whose clinical situation and progno-
sis differ appreciably.
The strengths of this study include its prospective design, 
the use of widely validated and reliable measures, the utili-
zation of different scales, and a sizable sample of subjects 
with non-advanced, resected cancer from different hospitals 
of all over Spain.
In conclusion, these results add to the growing body of 
knowledge about the adequate reliability and validity prop-
erties of the SWLS and the strong gender, age, and tumor 
location invariance. These findings are pertinent, as they 
prove that the SWLS can be used as a complementary meas-
ure to evaluate psychological adjustment in individuals with 
cancer.
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